NCT05415098 2022-11-16Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or LymphomasAscentage Pharma Group Inc.Phase 1 Unknown90 enrolled
NCT02637531 2022-04-04A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549Infinity Pharmaceuticals, Inc.Phase 1 Unknown219 enrolled